Dormant no more: Brain protein’s hidden role may reshape psychiatric and neurological treatments

In a new research report, scientists at Johns Hopkins Medicine say they have identified a potential target for drugs that could dial up or down the activity of certain brain proteins in efforts to treat psychiatric disorders, such as anxiety and schizophrenia, and a neurological condition that affects movement.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup